Insider Buying: Cyclopharm Limited (ASX:CYC) Insider Purchases 33,000 Shares of Stock

Cyclopharm Limited (ASX:CYC) insider John Wigglesworth acquired 33,000 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were bought at an average price of A$1.54 ($1.06) per share, with a total value of A$50,754.00 ($35,002.76).

Cyclopharm Price Performance

The company has a debt-to-equity ratio of 11.72, a quick ratio of 4.68 and a current ratio of 4.38.

Cyclopharm Company Profile

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.